Get started
Author

Edith Jasny

Observed name: Jasny, Edith
Institution: CureVac (Germany)
OpenAlex ID: A5061114734
New Vaccine Technologies to Combat Outbreak Situations
2018 · Susanne Rauch, Edith Jasny, et al. · Frontiers in Immunology · 595
PDF
Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques
2009 · Christiane Stahl-Hennig, Martin Eisenblätter, et al. · PLoS Pathogens · 199
PDF
Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response
2017 · Darin K. Edwards, Edith Jasny, et al. · Journal of Translational Medicine · 187
PDF
Advances in RNA Vaccines for Preventive Indications: A Case Study of a Vaccine against Rabies
2019 · Nicole Armbruster, Edith Jasny, et al. · Vaccines · 96
PDF
A novel RNA‐based adjuvant combines strong immunostimulatory capacities with a favorable safety profile
2014 · Regina Heidenreich, Edith Jasny, et al. · International Journal of Cancer · 80
A Macaque Model to Study Vaginal HSV-2/Immunodeficiency Virus Co-Infection and the Impact of HSV-2 on Microbicide Efficacy
2009 · Federica Crostarosa, Meropi Aravantinou, et al. · PLoS ONE · 63
PDF
mRNA Vaccine Protects against Zika Virus
2021 · Lex G. Medina-Magües, Janina Gergen, et al. · Vaccines · 54
PDF
A New RNA-Based Adjuvant Enhances Virus-Specific Vaccine Responses by Locally Triggering TLR- and RLH-Dependent Effects
2017 · Annett Ziegler, Claudia Soldner, et al. · The Journal of Immunology · 50
Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses
2023 · Fredrika Hellgren, Alberto Cagigi, et al. · Nature Communications · 49
PDF
A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses
2022 · Klara Lenart, Fredrika Hellgren, et al. · Molecular Therapy — Methods & Clinical Development · 40
A Tonsillar PolyICLC/AT-2 SIV Therapeutic Vaccine Maintains Low Viremia Following Antiretroviral Therapy Cessation
2010 · Panagiotis Vagenas, Meropi Aravantinou, et al. · PLoS ONE · 23
PDF
Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal models
2023 · Lex G. Medina-Magües, Janine Mühe, et al. · npj Vaccines · 19
PDF
IL-12-Impaired and IL-12-Secreting Dendritic Cells Produce IL-23 upon CD154 Restimulation
2008 · Edith Jasny, Martin Eisenblätter, et al. · The Journal of Immunology · 16
Nocardia farcinica Activates Human Dendritic Cells and Induces Secretion of Interleukin-23 (IL-23) Rather than IL-12p70
2012 · Martin Eisenblätter, Ariane Buchal, et al. · Infection and Immunity · 12
An mRNA-based FimH nanoparticle vaccine against uropathogenic Escherichia coli is highly immunogenic in rodents
2025 · Sandro Roier, Roberto Adamo, et al. · Frontiers in Immunology · 11
PDF
Characterization of Peripheral and Mucosal Immune Responses In Rhesus Macaques on Long-Term Tenofovir and Emtricitabine Combination Antiretroviral Therapy
2012 · Edith Jasny, Suzanne Geer, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 9
The Attenuated Brucella abortus Strain 19 Invades, Persists in, and Activates Human Dendritic Cells, and Induces the Secretion of IL-12p70 but Not IL-23
2013 · Mario Weinhold, Martin Eisenblätter, et al. · PLoS ONE · 6
PDF
Induction of neutralising antibodies restricts the use of human granulocyte/macrophage colony stimulating factor for vaccine studies in rhesus macaques
2004 · Martin Eisenblätter, Christiane Stahl-Hennig, et al. · Vaccine · 6
Author Correction: Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses
2023 · Fredrika Hellgren, Alberto Cagigi, et al. · Nature Communications · 5
PDF
Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses
2023 · Hellgren, Fredrika, Cagigi, Alberto, et al. · RePEc: Research Papers in Economics · 3
Self-adjuvanted RNActive® vaccine induces local immune responses at the injection site leading to potent adaptive immunity in mice and humans
2014 · Aleksandra Kowalczyk, Fatma Döner, et al. · Journal for ImmunoTherapy of Cancer · 1
PDF
An mRNA-based FimH nanoparticle vaccine against uropathogenic Escherichia coli confers protection in a mouse model of recurrent urinary tract infection
2026 · Sandro Roier, Jessica M. Devant, et al. · Frontiers in Immunology
PDF
Seasonal influenza mRNA vaccine induces stronger innate and comparable or better adaptive responses than licensed inactivated vaccines
2026 · Erick Bermúdez-Méndez, Klara Lenart, et al. · npj Vaccines
PDF
RNActive®-An mRNA-based vaccine technology for next generation prophylactic vaccines
2018 · Edith Jasny
Analysis of signaling pathways underlying the immunoenhancing effects of a new RNA-based adjuvant
2017 · Annett Ziegler, Soldner Claudia, et al. · 日本インターフェロン・サイトカイン学会学術集会抄録集
Works count: 35
Citation count: 1,524
H-index: 13
I10-index: 15
Year
Topic
Type